The Globe and Mail reports in its Wednesday, July 9, edition that TD Cowen analyst Cherilyn Radbourne believes new investors may "stay on the sidelines" after ATS chief executive officer Andrew Hider's departure, but expects existing shareholders to remain confident due to the "strong growth platform" he developed and the potential for a solid candidate pool. The Globe's David Leeder writes that ATS shares dropped over 8 per cent after the automation solutions provider said Mr. Hider is leaving to pursue a new leadership opportunity outside the industry. He had been in the role since 2020. Ms. Radbourne continues to rate ATS "buy." Her share target tumbled $10 to $49. Analysts on average target the shares at $48.63. Ms. Radbourne says in a note: "Based on Mr. Hider's leadership calibre, the potential for another organization to recruit him was always a risk, but the announcement still came as a surprise. Mr. Hider is leaving ATS to become CEO of Baxter, a global med-tech leader; therefore, we do not interpret his departure as a signal regarding his view of ATS's future prospects. We see the timing as unfortunate, because ATS is exiting a very difficult F2025. That said, the company has a near-record backlog of $2-billion."